-
1 Comment
Metalabs Co., Ltd is currently in a long term uptrend where the price is trading 16.2% above its 200 day moving average.
From a valuation standpoint, the stock is 45.7% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 0.8.
Metalabs Co., Ltd's total revenue sank by 21.4% to $16B since the same quarter in the previous year.
Its net income has dropped by 11.5% to $-14B since the same quarter in the previous year.
Finally, its free cash flow grew by 522.9% to $1B since the same quarter in the previous year.
Based on the above factors, Metalabs Co., Ltd gets an overall score of 3/5.
| CurrencyCode | KRW |
|---|---|
| Industry | Apparel Manufacturing |
| ISIN | KR7090370008 |
| Sector | Consumer Cyclical |
| Exchange | KO |
| Market Cap | 14B |
|---|---|
| Dividend Yield | 0.0% |
| Target Price | 8070 |
| PE Ratio | None |
| Beta | -0.39 |
Metalabs Co., Ltd. primarily provides clothing in South Korea. It also manufactures and distributes prescription drugs, medical devices, and masks; develops peptide-based bio products; offers medical management services; and distributes cosmetics, as well as operates dating applications. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 090370.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
